
21
J Gandhara Med Dent Sci
October - December 2025
the research examination of Pawlicka, MA et al.
Reported in 2022 that the experienced isoflavonoid is
intimately connected to its strength. Increasing the
concentrations of Genistein (50μM and 100μM)
reduces the number of fibroblast cells with longer
contact times (48 hours). However, the decrease in
strength of Genistein (10 & 20μM) exhibited a higher
number of dermal fibroblasts. 23 Our research study
results further support the thought that the cytotoxic
activities of Papaya leaves (RL) might vary depending
on the extraction solvent utilized. Overall, our findings
highlight the potential of Papaya leaves, particularly the
acetone extract from the RL variety, as a source of
novel anti-proliferative agents. The research findings
reveal the cytotoxic potential of Papaya Leaves against
the cervical HeLa cell line. Both acetone and n-hexane
extracts exhibited cancer cell growth inhibition; their
potency was insignificant at the tested concentrations.
The result for the prostate-PC3 cell line showed that the
acetone extract of Papaya RL Leaf yielded a negligible
effect when dispensed at a concentration of 30μM,
illustrating a reasonable % inhibition (mean ± SD) of
30.5 ± 0.69. Even though it demonstrated considerable
activity. The cytotoxicity of the acetone extract is
recorded against BJ fibroblasts, but not in HeLa or PC3
cells, possibly due to the presence of mid-polarity
phytoconstituents that exert nonspecific toxic properties
on normal cells. In contrast, cancer cells evade death by
modulating apoptosis or efflux mechanisms. Further
phytochemical studies are necessary to understand the
selectivity better. Likewise, the n-hexane extract of
Papaya Leaf, at a concentration of 30 μM, showed a
comparatively low inhibition rate of 8.01%, indicating
it to be inactive. In 2020, Abankwa JK et al.
investigated the antioxidant and anti-cancer activities of
Moringa oleifera, Phyllanthus amarus, and Carica
papaya. Aqueous extract of Carica papaya in particular
exhibited significant anti-prostate cancer activity,
selective enough toward PC3 prostate cancer cells to
record an IC₅₀ value of 45.68 ± 1.16 µg/mL and a very
high selectivity index (SI = 18). This provides evidence
for the therapeutic promise of C. papaya as a rich
source of bioactive compounds capable of selectively
targeting cancer cells with minimal effects on normal
cells, thereby supporting its traditional application in
complementary medicine. There remains a further need
to deepen mechanistic and in vivo studies to validate its
application in the management of prostate cancer.
25
Further optimization of Papaya leaf extracts is
recommended to enhance their cytotoxic efficacy across
different cell lines. Future studies should focus on
identifying and isolating specific bioactive components
responsible for the observed moderate activity against
the BJ-cell line, with the goal of developing targeted
therapies.
LIMITATIONS
This study is limited by its reliance on in-vitro assays,
which may not fully replicate the complex interactions
in living organisms. Only two extraction solvents were
tested, which may not capture the complete
phytochemical potential of papaya leaves. Furthermore,
the study focused on a limited number of cell lines, and
the sample size for assays was relatively small,
restricting the generalizability of the findings.
Additional in-vivo studies, broader solvent systems, and
mechanistic analyses are required to validate and
expand upon these results.
CONCLUSIONS
The acetone extract displays significant activity against
BJ-cells (59.5, 60.48, and 61.2%), while the n-hexane
extract is inactive, based on a cut-off value of 50%.
Both extracts have minimal effects on HeLa cells and
none on PC3 Cells, falling short of the predefined cut-
off value of 50%.
CONFLICT OF INTEREST: None
FUNDING SOURCES: None
REFERENCES
1. Compton C. The Nature and Origins of Cancer. In: Cancer: The
Enemy from Within: A Comprehensive Textbook of Cancer’s
Causes, Complexities and Consequences. 2020:1-23.
https://doi.org/10.1007/978-3-030-40651-6.
2. Salas-Benito D, Pérez-Gracia JL, Ponz-Sarvisé M, Rodriguez-
Ruiz ME, Martínez-Forero I, Castañón E, et al. Paradigms on
immunotherapy combinations with chemotherapy. Cancer
Discovery. 2021;11(6):1353-67. https://doi.org/10.1158/2159-
8290.CD-20-1312. PMID: 33712487
3. Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey
DK, et al. Cancer chemotherapy and beyond: Current status,
drug candidates, associated risks and progress in targeted
therapeutics. Genes & Diseases. 2023;10(4):1367-401.
https://doi.org/10.1016/j.gendis.2022.02.007. PMID: 37397557
4. Yadav A, Singh S, Sohi H, Dang S. Advances in delivery of
chemotherapeutic agents for cancer treatment. AAPS
PharmSciTech. 2022;23(1):1-14. http://doi.org/10.1208/s122
-49021-02174-9. PMID:34907501
5. Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D,
Iurciuc S, et al. Plant-derived anti-cancer compounds as new
perspectives in drug discovery and alternative therapy.
Molecules. 2021;26(4):1109.
https://doi.org/10.3390/molecules26041109.
6. Siddiqui AJ, Jahan S, Singh R, Saxena J, Ashraf SA, Khan A, et
al. Plants in anti-cancer drug discovery: from molecular
mechanism to chemoprevention. Biomed Research
International. 2022;2022:5425485.
https://doi.org/10.1155/2022/5425485.
7. Nafiu AB, Alli-Oluwafuyi AM, Haleemat A, Olalekan IS,
Rahman MT. Papaya (Carica papaya L., pawpaw). In:
Nonvitamin and Nonmineral Nutritional Supplements. Elsevier;
2019. p. 335-59. https://doi.org/10.1016/B978-0-12-812491-
8.00048-5.
In-Vitro Cytotoxic Potential of Carica Papaya Leaves